MEDISPA.PRO
Ministry of Health code: A12.09.002.003 Axis M0 · Introductory check-up and longevity biomarkers CEBM: Level A (Functional diagnostics and check-up)

Cardiopulmonary exercise testing (CPET spiroergometry / VO2max)

Cardiopulmonary Exercise Testing (CPET / VO2max)

Industry clinical and economic procedure passport. Full biological mechanism (MoA), patient preparation protocol, first-choice equipment fleet, integration into the resort's master treatment rooms and market price benchmarks.

To the procedure catalogue Equipment fleet Integration treatment rooms Rates and economics
Session duration
60 min
Turnover: ~75 min
Recommended course
1 sessions
once every 6 months (dynamic monitoring of exercise tolerance)
Throughput capacity
6 pts
per 8-hour shift
Median rate
2 250 ₽
1 588 ₽ – 3 400 ₽
Course cost
2 250 ₽
at market median
Publication volume
Level A
8 publ. in PubMed

Clinical profile

Exercise test on a cycle ergometer or treadmill with expired gas analysis: measures peak oxygen uptake (VO₂peak), anaerobic threshold and ventilatory efficiency. The method is standardised by international guidelines; the cardiorespiratory fitness it measures is one of the strongest predictors of mortality and chronic disease.

Every statement links to a publication in the list below. This is a snapshot of published research, not a final assessment of the method: international practice and integrated protocols often run ahead of official publications. Draft based on published research; requires review by a physician. Revision: 2026-10-17.

Mechanism of action

  • The test assesses the combined work of the heart, lungs and muscles under increasing load; its interpretation is described in scientific statements of cardiology societies. [4, 5]

Where studies show an effect

  • Assessment of cardiorespiratory fitness as a prognostic factor: high fitness is consistently associated with lower risk of death and chronic disease (review of meta-analyses, more than 20.9 million observations). [1]
  • People with a maximal aerobic capacity of 7.9 METs or higher have markedly lower mortality and incidence of CHD and CVD. [2]
  • Chronic lung disease: standardised use for diagnosis and assessment of exercise limitation. [6, 3]
  • Preoperative risk stratification and prognosis in specific heart diseases. [7, 8]

Open questions and study limitations

  • Large prospective studies are needed for preoperative assessment and prognosis in amyloid cardiomyopathy. [7, 8]

Safety

  • Test performance and interpretation are standardised in the ATS/ACCP and American Heart Association guidelines. [3, 4]

Protocol in studies

  • ERS standard: at least 3 minutes at rest, 3 minutes of unloaded exercise, 8–12 minutes of linearly increasing load (increments at least once a minute), then recovery of at least 2–3 minutes. [6]
Contraindications. Contraindications to exercise testing are determined by the functional diagnostics physician according to ATS/ACCP and AHA guidelines.

Equipment fleet and fit-out

Certified first-choice medical equipment and compatible device systems

Equipment registry
Base configuration (Hero Device)
Cortex MetaLyzer 3B / Cosmed Quark CPET cardiopulmonary exercise gas analysis system

Device platform with proven validation of the biological response. Includes built-in biofeedback sensor systems, patient protection protocols and precision dosing of exposure.

Certification: Russian Ministry of Health registration certificate / CE Medical Device Directive Class IIa/IIb.
Compatible platforms in the MEDISPA.PRO registry
Skillrun professional treadmill with adaptive cushioning
Medical device, Roszdravnadzor registration certificate / CE
In the registry →
Treadmill test (GE T-2100 or Schiller MTM 1500)
Medical device, Roszdravnadzor registration certificate / CE
In the registry →
Recline horizontal medical cycle ergometer with ECG monitoring
Medical device, Roszdravnadzor registration certificate / CE
In the registry →

Architectural integration and treatment rooms

Resort rooms housing the treatment station (with SanPiN norms and MEP loads)

All treatment rooms →
1.2.3 20.0 m² · Class V

Cardiorespiratory testing (VO2max, treadmill )

Diagnostic unit (functional, radiology, ultrasound diagnostics) · Equipment: 1 036 630 ₽

Treatment room passport →
2.3.4 100.0 m² · Class V

gym with exercise machines (cardio, strength)

Wellness, mindfulness and relaxation spaces · Equipment: 4 445 000 ₽

Treatment room passport →

Unit economics and resort price benchmarks

Market analysis based on a sample of premium sanatoriums, wellness hotels and preventive medicine clinics

Market price corridor
25th percentile (P25) 1 588 ₽
Market median 2 250 ₽
75th percentile (P75) 3 400 ₽

Median of prices in industry facilities' price lists, 2026

Basis of the price benchmark

Prices for this procedure appear in the price lists of 4 industry facilities; the median and interquartile range across facilities are shown (each facility counts once).

Evidence base

The method is standardised by international guidelines; the prognostic value of the measured fitness is confirmed by meta-analyses of millions of observations.

Publication level A · Plenty of data
  1. 1.
    Cardiorespiratory fitness is a strong and consistent predictor of morbidity and mortality among adults: an overview of meta-analyses representing over 20.9 million observations from 199 unique cohort studies.
    Br J Sports Med, 2024 · Review of meta-analyses · PMID 38599681
    High cardiorespiratory fitness is consistently associated with lower risk of death and chronic disease.
  2. 2.
    Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis.
    JAMA, 2009 · Meta-analysis · PMID 19454641
    Better fitness means lower risk of death and CHD/CVD; the threshold is about 7.9 METs.
  3. 3.
    ATS/ACCP Statement on cardiopulmonary exercise testing.
    Am J Respir Crit Care Med, 2003 · ATS/ACCP guidelines · PMID 12524257
    International standard for performing and interpreting the cardiopulmonary exercise test.
  4. 4.
    Clinician's Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association.
    Circulation, 2010 · AHA scientific statement · PMID 20585013
    A clinician's guide to cardiopulmonary exercise testing in adults.
  5. 5.
    EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations.
    Circulation, 2012 · EACPR/AHA scientific statement · PMID 22952317
    Recommendations on interpreting test data in specific patient groups.
  6. 6.
    ERS statement on standardisation of cardiopulmonary exercise testing in chronic lung diseases.
    Eur Respir Rev, 2019 · ERS statement · PMID 31852745
    Standardisation of the test protocol in chronic lung disease.
  7. 7.
    Cardiopulmonary exercise testing prior to radical cystectomy: a systematic review and meta-analysis.
    BJU Int, 2024 · Systematic review and meta-analysis · PMID 39258430
    Before radical cystectomy, poorer test results are associated with higher 90-day mortality.
  8. 8.
    Cardiopulmonary exercise testing predicts prognosis in amyloid cardiomyopathy: a systematic review and meta-analysis.
    ESC Heart Fail, 2023 · Systematic review and meta-analysis · PMID 37264762
    In amyloid cardiomyopathy, the test helps identify patients at increased risk of death.

Publications were found in PubMed; titles and journals are given verbatim, conclusions are a brief summary of the abstracts under the conditions of the specific studies. The level shows the volume of published data, not the value of the method: A — Plenty of data: consistent systematic reviews and meta-analyses of RCTs; B — Some data: reviews or several RCTs, results are heterogeneous; C — Little data: single RCTs or controlled studies; D — Scarce data: mainly reviews, observational and experimental studies. The passport is updated as new work is published and with regard to international practice.